Search hospitals > Colorado > Littleton
Rocky Mountain Cancer Centers-Littleton
Claim this profileLittleton, Colorado 80120
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
185 reported clinical trials
9 medical researchers
Summary
Rocky Mountain Cancer Centers-Littleton is a medical facility located in Littleton, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers-Littleton is involved with conducting 185 clinical trials across 364 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Manojkumar Bupathi, MD, MS, Robert M. Jotte, and Sami Diab.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder5 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Manojkumar Bupathi, MD, MSRocky Mountain Cancer Centers - Colorado Springs, N. Nevada1 year of reported clinical research
Studies Cancer
Studies Ovarian Cancer
9 reported clinical trials
21 drugs studied
Robert M. JotteGSK Investigational Site3 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
11 drugs studied
Sami DiabRocky Mountain Cancer Centers7 years of reported clinical research
Studies Breast Cancer
Studies Ovarian Cancer
5 reported clinical trials
11 drugs studied
Clinical Trials running at Rocky Mountain Cancer Centers-Littleton
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Bladder Cancer
Melanoma
Cutaneous Melanoma
Squamous Cell Carcinoma
Colorectal Cancer
Gastroesophageal Junction Adenocarcinoma
IMRT vs. APBI
for Early Stage Breast Cancer
In the setting of radiotherapy as part of breast-conservation therapy for patients with early stage breast cancer, the novel planning and delivery method of intensity modulated radiotherapy is an effective and safe alternative to the commonly-used standard 3D-conformal external beam radiotherapy, spares more normal breast and lung tissue, and may lead to improved clinical outcomes.
Recruiting2 awards Phase 311 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Littleton?
Rocky Mountain Cancer Centers-Littleton is a medical facility located in Littleton, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Rocky Mountain Cancer Centers-Littleton is involved with conducting 185 clinical trials across 364 conditions. There are 9 research doctors associated with this hospital, such as Nicholas DiBella, Manojkumar Bupathi, MD, MS, Robert M. Jotte, and Sami Diab.